Iovance Biotherapeutics Inc. buy Chardan Capital
Start price
20.02.24
/
50%
€10.58
Target price
20.02.25
€31.41
Performance (%)
9.83%
Price
15:43
€11.62
Summary
This prediction is currently active. With a performance of 9.83%, the BUY prediction by Chardan_Capital for Iovance Biotherapeutics Inc. is trending in the right direction. This prediction currently runs until 20.02.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 1.006% | 1.006% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Chardan_Capital for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Chardan Capital from $29.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Chardan_Capital for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.53
16.08.23
16.08.23
€26.61
16.08.24
16.08.24
78.00%
15:43
15:43
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.49
10.08.23
10.08.23
€26.26
10.08.24
10.08.24
71.24%
15:43
15:43
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.85
01.03.23
01.03.23
€27.17
01.03.24
01.03.24
127.70%
02.03.24
02.03.24